Our phase II study results demonstrating high efficacy and low toxicity for a weekly schedule of high-dose, 24-hour infusional 5-fluorouracil(5-FU)/folinic acid (HD5-FU/FA) in intensively pretreated patients with metastatic
Christian Müller, MD
Advertisement
Articles by Christian Müller, MD
Advertisement
Latest Updated Articles
- Infusional 5-FU, Folinic Acid, Paclitaxel, and Cisplatin for Metastatic
Published: April 1st 1997 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Lurbinectedin/Atezolizumab Maintenance in ES-SCLC
2
Trastuzumab Deruxtecan Regimen Accepted for Review in HER2+ Breast Cancer
3
Uncovering Subsequent Research Considerations for Tarlatamab in ES-SCLC
4
FDA Grants Fast Track Designation to Novel PIK3α Inhibitor in Breast Cancer
5
